ExpreS2ion will participate in key industry and investor events
Hørsholm, Denmark, April 7, 2022 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") will participate and hold presentations at key industry and investor events in the coming month. These include the World Vaccine Congress (April 18-21), a Q&A session covering the 2022 Rights Issue (April 25), Økonomisk Ugebrev Life Science Investor Conference (April 27), PEGS Summit (May 2-6), and the ESMO Breast Cancer Meeting (May 3-5).By attending relevant industry and investor events, the company aims to increase the awareness of the ExpreS[2] technology platform